The DOI matches its Crossref record.
In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody.
Open accessAbstract
BALB/c mice were injected intravenously with three different monoclonal antibodies (mAbs) specific for complement receptor 1 (CR1). Two of the mAbs crossreacted with CR2. 24 h later, the mice were immunized with horse erythrocytes or keyhole limpet hemocyanin (KLH), and the primary antibody response was measured. One of the anti-CR antibodies, 7G6, suppressed greater than 99% of the direct plaque-forming cell response against horse red blood cells (HRBC). The same antibody markedly suppressed the serum antibody responses to both HRBC and KLH. To be optimally suppressive, the mAb had to be injected before suboptimal concentrations of antigen. The other two complement receptor-specific antibodies had very moderate, if any, effects on the antibody response. 7G6 was able to downregulate CR1 and CR2 on the surface of B cells and, in addition, to inhibit rosette formation with C3d-coated sheep erythrocytes (EC3d). One of the antibodies with a weak effect downregulated only CR1. The other downregulated both CR1 and CR2, although not as efficiently as 7G6, and was unable to inhibit EC3d rosette formation. We conclude that the reason 7G6 is outstanding in its suppressive capacity is that it is the only mAb tested that functionally blocks CR2. The data suggest that CR2 is of crucial importance in the initiation of a normal antibody response to physiological concentrations of antigen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity
Dempsey, P. W., Allison, M. E. D., Akkaraju, S., Goodnow, C. C., & Fearon, D. T. (1996) · Science · doi:10.1126/science.271.5247.348 · Cited by 1,197
CD19: Lowering the Threshold for Antigen Receptor Stimulation of B Lymphocytes
Carter, R. H., & Fearon, D. T. (1992) · Science · doi:10.1126/science.1373518 · Cited by 674
Impairment of T-cell-dependent B-cell responses and B-l cell development in CD19-deficient mice
Rickert, R. C., Rajewsky, K., & Roes, J. (1995) · Nature · doi:10.1038/376352a0 · Cited by 664
THE ROLE OF COMPLEMENT AND COMPLEMENT RECEPTORS IN INDUCTION AND REGULATION OF IMMUNITY
Carroll, M. C. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.545 · Cited by 602
The Role of Complement in the Development of Systemic Lupus Erythematosus
Manderson, A. P., Botto, M., & Walport, M. J. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104549 · Cited by 538
Regulation of B Lymphocyte Responses to Foreign and Self-Antigens by the CD19/CD21 Complex
Fearon, D. T., Carroll, M. C., & Carroll, M. C. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.393 · Cited by 532
Ahearn, J. M., Fischer, M. B., Croix, D., Goerg, S., Ma, M., Xia, J., Zhou, X., Howard, R. G., Rothstein, T. L., & Carroll, M. C. (1996) · Immunity · doi:10.1016/s1074-7613(00)80433-1 · Cited by 482
The CD19/CR2/TAPA-1 Complex of B Lymphocytes: Linking Natural To Acquired Immunity
Fearon, D. T. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.127 · Cited by 474
Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2.
Molina, H., Holers, V. M., Li, B., Fung, Y., Mariathasan, S., Goellner, J., Strauss-Schoenberger, J., Karr, R. W., & Chaplin, D. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3357 · Cited by 465
Tedder, T. F., Inaoki, M., & Sato, S. (1997) · Immunity · doi:10.1016/s1074-7613(00)80418-5 · Cited by 383
Regulation of Antibody Responses via Antibodies, Complement, and Fc Receptors
Heyman, B. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.709 · Cited by 353
Self-citationCD19 of B Cells as a Surrogate Kinase Insert Region to Bind Phosphatidylinositol 3-Kinase
Tuveson, D. A., Carter, R. H., Soltoff, S. P., & Fearon, D. T. (1993) · Science · doi:10.1126/science.7684160 · Cited by 322
Fang, Y., Xu, C., Fu, Y.-X., Holers, V. M., & Molina, H. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.11.5273 · Cited by 320
Complement and viral pathogenesis
Stoermer, K. A., & Morrison, T. E. (2011) · Virology · doi:10.1016/j.virol.2010.12.045 · Cited by 255
Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage
Franzin, R., Stasi, A., Fiorentino, M., Stallone, G., Cantaluppi, V., Gesualdo, L., & Castellano, G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00734 · Cited by 93
“Interestingly, the increase in C3 plasma levels also controls the development of memory B cells in kidney diseases (251).”
Background
Metadata
- Authors
- Heyman, B., Wiersma, E. J., & Kinoshita, T.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1990-08-01
- Volume
- 172
- Issue
- 2
- Pages
- 665-668
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2159134769
- Cited by
- 201
- References
- 0
- FWCI
- 4.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.